Success Stories: Postdoctoral Associate from China in the Field of Biochemistry Receives EB-1A Petition Approval 9 Days after Filing

Client’s Testimonial:

“Thank you for your dedication and hard work. I am excited to hear this good news.”

On February 25th, 2016, we received another EB-1A (Alien of Extraordinary Ability) approval for a Postdoctoral Associate in the Field of Biochemistry (Approval Notice).

General Field: Biochemistry

Position at the Time of Case Filing: Postdoctoral Associate

Country of Origin: China

Service Center: Texas Service Center (TSC)

State of Residence at the Time of Filing: Texas

Approval Notice Date: February 25th, 2016

Processing Time: 9 days (Premium Processing requested)

Case Summary:

A postdoctoral associate from China contracted North America Immigration Law Group (WeGreened.com) to file an EB-1A (Alien of Extraordinary Ability) petition on his behalf. Thanks to Premium Processing, our client received an approval notice from the USCIS just nine days after we filed the case.

As part of our services, we helped our client narrow down a list of potential recommenders who could provide strong recommendation letters to fortify our EB-1A petition packet. The six recommenders who agreed to lend their support are experts in the field of biochemistry, and like our client, their opinions are respected throughout the field. We used these letters as additional evidence to the abundance of information that we had gathered on our client’s successful professional exploits.

“[Client’s] educational background is vast and includes expertise in cell biology, biotechnology, and even computer science, as he has mastery of several programming languages.”

Our client’s Ph.D. in Cell Biology clearly shows that he has dedicated many years to mastering the core of his field. His research efforts serve as further proof that he is a leading researcher whose contributions benefit not just other biochemists, but the entire scientific community.

“…a significant amount of citations in the fields of cell biology and biochemistry and attests to the widespread implementation and influence of [Client’s] research.”

Our comprehensive EB-1A petition packet also highlighted our client’s citation, publication and peer review record. At the time of filing, our client had published 13 scientific journal articles that had gathered 246 citations, and had conducted 22 peer reviews for multiple high impact scientific journals.

“The first project is a continuing work that seeks to build and apply a novel imaging system in order to more effectively study lipid, protein, and small biomolecule dynamics…”

Our legal team paid special attention to understanding and detailing our client’s various research projects on the molecular mechanism underlying phototransduction, neuropeptide sorting, lipid metabolism, and aging. We established that his work contributes to the study, diagnosis, and treatment of debilitating, fatal, and costly health conditions, ultimately providing the tools necessary for lowering mortality rates and medical expenditures associated with these diseases in the United States.

“[Client’s] research in this area would contribute greatly to the medical research in the United States and it is worth allowing his work to continue unimpededly.”

We are pleased that the USCIS approved our client’s EB-1A petition. We believe that our client’s strong credentials and our meticulously presented petition lent a hand in the approval process. We would like to congratulate our client on this milestone and we wish him the best as he continues to advance his field of biochemistry.

North America Immigration Law Group (Chen Immigration Law Associates) is a U.S. immigration law firm dedicated to representing corporations, research institutions, and individuals from all 50 U.S. states regarding I-140 immigration petitions. We specialize in employment-based immigration petition and have a proven record of high success rate for the categories of: EB2-NIW (National Interest Waiver), EB1-A (Alien of Extraordinary Ability), EB1-B (Outstanding Researcher/Professor) and O-1 (Alien of Extraordinary Ability).

Our Ten Thousand I-140 Approvals Provide Unprecedented Insight into the USCIS Adjudication Trend

With more than 47,000 EB-1A, EB-1B, EB-2 NIW and O-1 cases approved, we have first hand information on the manner in which the USCIS adjudicate I-140 cases. As the USCIS has constantly changed its adjudication standards for the EB-1A, EB-1B and EB-2 NIW categories, our firm's huge database of successful cases gives you unprecedented insight to USCIS adjudication trends. We carefully analyze the data for all of our cases and apply the results of our analyses toward giving our clients up-to-date advice and adapting our strategies such that we remain on par with the ever-shifting landscape of immigration law in the U.S. With us, you will always have access to important updates, strategies, and information so that you can make the most informed decisions about your case.

We Have Helped Hundreds and Thousands of Clients with Credentials and Backgrounds Similar to Yours

With our exceedingly large number of successful petitions, no matter what credentials you have, no matter your background and field of expertise, no matter your visa status or nationality, chances are we have helped hundreds or even thousands of clients just like you. Our clients are usually impressed with how well we understand their research and work. Our insight and understanding stems from the fact that we have handled many cases with elements similar to yours already, and this helps us devise the best strategies for each individual petition.

Vast Majority of Clients Came to Us Because of Referrals

For years, our firm has attracted new clients based solely on word of mouth, recommendations, and the positive collaboration experiences shared with them by their friends and family. We take pride in our reputation and work hard to ensure that we provide a green card application experience that our clients are happy to share with their friends and colleagues. That is how our approved cases grew from 600 in 2013 to over 47,000 in 2023.